Codes / ICD10CM / M1A.47

M1A.47 Other secondary chronic gout, ankle and foot

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Secondary Chronic Gout, Ankle and Foot

Summary

Other secondary chronic gout, ankle and foot is a form of arthritis affecting the ankle and foot joints, resulting from elevated uric acid levels due to an identifiable underlying condition or cause. It leads to recurrent joint inflammation and potential tissue damage, with symptoms that may persist over time. Advanced stages can involve the formation of tophi (urate crystal deposits) in the ankle and foot areas.

Causes

Other secondary chronic gout, ankle and foot arises from an underlying condition that disrupts uric acid metabolism, causing accumulation in the blood. This can stem from overproduction of uric acid or reduced renal clearance due to factors like chronic kidney disease, certain medications, or hematologic disorders. Over time, urate crystals deposit in the ankle and foot joints and surrounding tissues, triggering inflammation.

Risk Factors

  • Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
  • Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
  • Chronic kidney disease or renal impairment
  • History of gout or hyperuricemia
  • Exposure to substances that disrupt uric acid excretion

Symptoms

  • Recurrent episodes of intense ankle or foot pain, often with swelling and redness
  • Persistent warmth and tenderness in affected joints
  • Formation of tophi (hard, painless lumps) under the skin
  • Stiffness and limited joint mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and laboratory tests. Joint fluid analysis may confirm the presence of urate crystals. Imaging studies, such as X-rays or ultrasound, can assess joint damage or tophi. Underlying conditions contributing to uric acid elevation are also investigated.

Treatment Options

Treatment focuses on managing symptoms, reducing uric acid levels, and addressing the underlying cause. Medications may include anti-inflammatory drugs for acute flare-ups, urate-lowering therapies, and treatments for the primary condition. Lifestyle modifications, such as dietary changes, are often recommended.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and adherence to treatment. Chronic management is typically required to prevent flare-ups and complications. Regular follow-up with healthcare providers ensures monitoring of uric acid levels and joint health.

Complications

Untreated or poorly managed gout can lead to joint deformity, chronic pain, and increased risk of kidney stones or kidney disease. Tophi may develop, causing tissue damage or nerve compression.

Lifestyle & Prevention

  • Limit alcohol and high-purine foods (e.g., red meat, seafood)
  • Maintain a healthy weight and stay hydrated
  • Follow prescribed medication regimens consistently
  • Avoid medications that may elevate uric acid levels unless necessary

When to Seek Professional Help

Seek medical attention if experiencing severe joint pain, swelling, or redness, or if symptoms worsen despite home care. Prompt evaluation is important for managing flare-ups and preventing long-term damage.

Tips for Medical Coders

Document the specific site (ankle and foot) and any underlying cause of secondary gout. Ensure clinical notes support the diagnosis and specify the affected joints. Code M1A.47 is appropriate when the condition is localized to the ankle and foot and secondary to an identifiable cause.

Book a walkthrough

M1A.47 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.